The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Following this weekend’s strong opening for Goat, Sony Pictures Animation will open its next original feature toon, Buds, on Wednesday, Dec. 22, 2027. The only other movie dated for Dec. 22 is a ...
Hosted on MSN
Solar eclipse 2026: Google’s ‘ring of fire’ animation goes viral, here’s how to activate it
To mark the first solar eclipse of 2026, Google has launched a special ‘Ring of Fire’ interactive animation on its search page. This feature allows people across the world to experience the annular ...
This is read by an automated voice. Please report any issues or inconsistencies here. Animation is the backbone of the film industry, boosting the global box office year after year. But such ...
Passengers on Metro-North and Long Island Rail Road trains could face $8 fines if they keep waiting until after the train leaves to activate their mobile tickets. By Camille Baker Starting on Jan. 4, ...
In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte globulin (ATG), induces injury to blood vessels in the liver. According to the ...
The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...
(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...
From weak theatrical intent to cultural controversy, Disney animation faces major challenges even as it experiments with fresh formats and new IP. Jeff Gritchen/MediaNews Group/Orange County Register ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...
Richmond tech accelerator Activation Capital announced Tuesday that it has appointed Michael Steele as president and CEO. He succeeds Robert Ward, who has served as interim CEO since July 2024. Ward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results